-
-
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Autochthonous dengue in two Dutch visiting Département Var, Southern France (July 2020)
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Clinical diagnosis and management of dengue
PAHO -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue Clinical Case Management
CDC -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Global, regional, and national dengue burden from 1990 to 2017
Takeda2 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021